Le Registre des lobbyistes
Actifs
-
Dernière mise à jour le :
2024-05-22
| Objets | Détails | Catégories |
|---|---|---|
|
Développement économique,
Industrie,
Recherche et développement,
Santé,
Sciences et technologies
|
Advancing the recommendations made by the Health & Biosciences Economic Strategy Table to grow the medical technology industry in Canada.
|
Politique ou Programme
|
|
Affaires étrangères,
Développement économique,
Industrie,
Marchés publics,
Recherche et développement,
Santé,
Sciences et technologies
|
Discussions re. Policies to incent global medical technology companies to invest their R&D dollars in Canada, changes to the Scientific Research and Experimental Development tax credit and the impact on medical technology companies in Canada, the adoption of a common national framework to measuring health outcomes resulting in greater efficiencies and lower costs.
|
Politique ou Programme
|
|
Environnement,
Industrie,
Marchés publics,
Recherche et développement,
Santé,
Sciences et technologies
|
Environmental regulation of Medical Devices (Canadian Environment Protection Act (CEPA), Chemicals Management Plan, provincial Stewardship regulations), Addressing issues and providing advice related to Medical Devices concerned by these regulations and participation in legislative/regulatory processes with the intent of seeking reasonable approaches based on scientific evidence and revising policies where needed.
|
Règlement
|
|
Développement économique,
Industrie,
Marchés publics,
Recherche et développement,
Santé,
Sciences et technologies,
Vie privée et Accès à l'information
|
Health Canada - Health Technology Assessment (HTA) and the role of the Canadian Agency for Drugs and Technologies in Health (CADTH), GS1 (Global Standards 1) Canada, Vendor Credentialing, the removal of regulatory barriers to build an innovation economy and provide funding to grow a Canadian Artificial Intelligence & Digital Health cluster that will be globally competitive.
|
Politique ou Programme
|
|
Développement économique,
Industrie,
Marchés publics,
Recherche et développement,
Santé,
Sciences et technologies
|
Health Technology Assessment (HTA) - Providing advice and evidence related to the 'Value of Technology' in order to assist in the process of establishing proper medical device funding and reimbursement, contribution to the process of HTA with the intent of seeking reasonable approaches based on scientific evidence and changing reimbursement policies where needed.
|
Règlement
|
|
Développement économique,
Industrie,
Marchés publics,
Recherche et développement,
Relations fédérales-provinciales,
Santé,
Sciences et technologies
|
Innovation, Science and Economic Development Canada - advocating that the federal government work across all government relevant Ministries and with key stakeholders to advance the adoption of novel and innovative health innovations and grow the medical technology industry in Canada including forming a permanent cross ministerial and stakeholder collaborative roundtable/advisory group. Advocating for the development of a commercialization framework and adoption of medical technologies & health innovations strategy in Canada.
|
Politique ou Programme
|
|
Industrie,
Santé,
Sciences et technologies
|
Medical Device Bureau: discussions re. a program that assesses safety, effectiveness and quality of medical devices with respect to the authorization for the sale of medical device technologies in Canada.
|
Politique ou Programme
|
|
Industrie,
Recherche et développement,
Santé,
Sciences et technologies
|
Medical Device Regulations (SOR/98-282) that require compliance by the medical device technology industry. Addressing issues and providing advice related to Medical Device Regulations in Canada; performance of Therapeutic Products Directorate, Health Canada; other related activities of Health Canada e.g. health protection legislative renewal, cost recovery/user fees, quality systems (ISO 13485), single-use device reuse, Regulatory Review of Drugs and Devices (R2D2). Participate in the legislative/regulatory process with the intent of seeking reasonable approaches based on scientific evidence and changing policies where needed.
|
Règlement
|
| Objets | Détails | Catégories |
|---|---|---|
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Advancing the recommendations made by the Health & Biosciences Economic Strategy Table to grow the medical technology industry in Canada.
|
Politique ou Programme
|
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Discussions re. Policies to incent global medical technology companies to invest their R&D dollars in Canada, changes to the Scientific Research and Experimental Development tax credit and the impact on medical technology companies in Canada, the adoption of a common national framework to measuring health outcomes resulting in greater efficiencies and lower costs.
|
Politique ou Programme
|
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Environmental regulation of Medical Devices (Canadian Environment Protection Act (CEPA), Chemicals Management Plan, provincial Stewardship regulations), Addressing issues and providing advice related to Medical Devices concerned by these regulations and participation in legislative/regulatory processes with the intent of seeking reasonable approaches based on scientific evidence and revising policies where needed.
|
Règlement
|
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Health Canada - Health Technology Assessment (HTA) and the role of the Canadian Agency for Drugs and Technologies in Health (CADTH), GS1 (Global Standards 1) Canada, Vendor Credentialing, the removal of regulatory barriers to build an innovation economy and provide funding to grow a Canadian Artificial Intelligence & Digital Health cluster that will be globally competitive.
|
Politique ou Programme
|
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Health Technology Assessment (HTA) - Providing advice and evidence related to the 'Value of Technology' in order to assist in the process of establishing proper medical device funding and reimbursement, contribution to the process of HTA with the intent of seeking reasonable approaches based on scientific evidence and changing reimbursement policies where needed.
|
Règlement
|
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Innovation, Science and Economic Development Canada - advocating that the federal government work across all government relevant Ministries and with key stakeholders to advance the adoption of novel and innovative health innovations and grow the medical technology industry in Canada including forming a permanent cross ministerial and stakeholder collaborative roundtable/advisory group. Advocating for the development of a commercialization framework and adoption of medical technologies & health innovations strategy in Canada.
|
Politique ou Programme
|
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Medical Device Bureau: discussions re. a program that assesses safety, effectiveness and quality of medical devices with respect to the authorization for the sale of medical device technologies in Canada.
|
Politique ou Programme
|
|
Il n'était pas requis d'associer l'objet aux détails sur l'objet lors de la soumission de cet enregistrement
|
Medical Device Regulations (SOR/98-282) that require compliance by the medical device technology industry. Addressing issues and providing advice related to Medical Device Regulations in Canada; performance of Therapeutic Products Directorate, Health Canada; other related activities of Health Canada e.g. health protection legislative renewal, cost recovery/user fees, quality systems (ISO 13485), single-use device reuse, Regulatory Review of Drugs and Devices (R2D2). Participate in the legislative/regulatory process with the intent of seeking reasonable approaches based on scientific evidence and changing policies where needed.
|
Règlement
|
Techniques de communication déjà utilisées ou qui seront utilisées au cours de l'engagement :
| Date | TCPD, Titre du poste | Institution gouvernementale | Objets |
|---|---|---|
| 2023-09-14 |
|
Santé, Industrie |